Clinical Trials
29
Trial Phases
4 Phases
Drug Approvals
1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (19 trials with phase data)• Click on a phase to view related trials
FDDA Utilization Study (FDDAU)
- Conditions
- Fatigue
- First Posted Date
- 2023-05-17
- Last Posted Date
- 2023-05-17
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 217
- Registration Number
- NCT05861492
- Locations
- 🇨🇭
QualiPro Schweiz AG, Kriens, Luzern, Switzerland
Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
- First Posted Date
- 2023-03-13
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT05766839
- Locations
- 🇧🇪
Universitair Ziekenhuis Gent, Gent, Belgium
🇬🇷Ippokratio Thessaloniki General Hospital, Thessaloníki, Thessaloniki, Greece
🇬🇷Pan and Aglaia Kyriakou Children's Hospital, Athens, Greece
Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
- First Posted Date
- 2019-03-25
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 1195
- Registration Number
- NCT03888066
- Locations
- 🇺🇸
Investigator Site 11-080, Alexander City, Alabama, United States
🇺🇸Investigator Site 11-041, Huntsville, Alabama, United States
🇺🇸Investigator Site 11-153, Phoenix, Arizona, United States
Pharmacodynamic & Safety of Patiromer in Children & Adolescents (2-<18 Yrs) With Chronic Kidney Disease and Hyperkalemia
- First Posted Date
- 2017-03-22
- Last Posted Date
- 2022-10-19
- Lead Sponsor
- Vifor Pharma, Inc.
- Target Recruit Count
- 23
- Registration Number
- NCT03087058
- Locations
- 🇺🇸
Investigator Site 1107, Palo Alto, California, United States
🇺🇸Investigator Site 1101, Kansas City, Kansas, United States
🇺🇸Investigator Site 1103, Baltimore, Maryland, United States